PRIMARY STUDY
Cannabinoids receptors in Covid-19: Perpetrators and victims
Key Findings: This review explains the anti-inflammatory properties of the endocannabinoid system (ECS), especially CB2 receptors, against inflammatory lung injury and viral infections as in COVID-19. It concludes that there may be useful targets in the ECS managing COVID-19 via their anti-inflammatory action and the suppression of inflammatory cytokines and signaling pathways.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Australia, Austria, Egypt, Iraq
Year of Pub: 2022
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Endocannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Chemotype: Chemotype I, Chemotype III
Receptors Studied: CB1, CB2, GPCR
Citation: Al-Kuraishy HM, et al. Cannabinoids Receptors in COVID-19: Perpetrators and Victims. Curr Med Chem. 2023; 30:3832-3845. doi: 10.2174/0929867329666220829145029
Authors: Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Batiha GE
